Insulet (PODD) Liabilities from Discontinued Operations (2015)

Insulet (PODD) posted Liabilities from Discontinued Operations of 5319000.0 for Q4 2015.

Insulet (PODD) Liabilities from Discontinued Operations (2015) Analysis & Trends

Insulet's Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 5319000.0 for Q4 2015.

Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 5319000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was 5319000.0 (changed N/A YoY) and the FY2015 annual result came in at 5319000.0, changed N/A from the prior year.
Liabilities from Discontinued Operations was 5319000.0 for Q4 2015 at Insulet.
Across five years, Liabilities from Discontinued Operations topped out at 5319000.0 in Q4 2015 and bottomed at 5319000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn
10	Insulet	11.52 Bn	11.04 Bn	529.10 Mn

Download Data

Date	Value
Dec 31, 2015	5.32 Mn
Dec 31, 2015	5.32 Mn